Search Results

• • 31 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial

  Authors:M Naumann and NJ LoweFrom:British Medical Journal (Vol. 323, Issue 7313) Peer-Reviewed

  Sept. 15, 20012,490 words Product/service eval... Botulinum toxin type A (Botox) appears to be effective for treating excessive sweating, a condition called hyperhidrosis. Patients must receive 10 to 15 injections in the underarm. In a study of 307 patients, 82% of...

• Botox may be effective for transformed migraine

  Author:Debbie LermanFrom:Family Practice News (Vol. 35, Issue 17)

  Sept. 1, 2005632 words Article PHILADELPHIA -- Botulinum toxin type A was found to be an effective, well-tolerated prophylactic treatment for patients with transformed migraine, researchers reported at the annual meeting of the American Headache...

• Botox

  From:Formulary (Vol. 45, Issue 4) Peer-Reviewed

  Apr. 201035 words Brief article 1160LOnabotulinumtoxin A (Botox, Allergan) for the treatment of spasticity in the flexor muscles of the elbow, wrist, and fingers in adults. Spasticity is common after stroke, traumatic brain injury, or the progression of...

• Botulism disaster uncovers fake botox market

  Author:Betsy BatesFrom:Family Practice News (Vol. 35, Issue 10)

  May 15, 20051,552 words Article Four doctors, including the director of oculofacial plastic surgery at the University of Kentucky, have been indicted on federal conspiracy charges involving mail and wire fraud and misbranding a drug in connection with...

• FDA approves botulinum toxin for glabellar lines

  From:Ophthalmology Times (Vol. 27, Issue 10) Peer-Reviewed

  May 15, 2002409 words Brief article Irvine, CA--The FDA has approved the use of botulinum toxin type A (Botox, Allergan, Irvine, CA) for temporary improvement in the appearance of moderate to severe glabellar lines in adult men and women 65 or younger....

• Botulinum toxin type A approval extends to glabellar lines : While not permanent, injection is minimally invasive and offers high patient satisfaction

  Author:Lynda ChartersFrom:Ophthalmology Times (Vol. 27, Issue 12) Peer-Reviewed

  June 15, 2002757 words Product/service eval... Reviewed by Jean Carruthers, MD, FRCS Vancouver, British Columbia--The FDA recently approved the injection of botulinum toxin type A (Botox Cosmetic, Allergan, Irvine, CA) to treat moderate to severe glabellar lines...

• Nurses told to stop giving Botox under group directions

  Author:Tamsin SnowFrom:Nursing Standard (Vol. 22, Issue 5) Peer-Reviewed

  Oct. 10, 2007386 words Brief article 1410LHealth regulators and the RCN held urgent talks this week about whether nurses who administer Botox under patient group directions (PGDs) are breaching professional rules. Last week the Nursing and Midwifery Council...

• Distant spread of toxin possible with Botox, says company

  From:Reactions Weekly (Issue 1236)

  Jan. 24, 2009225 words Brief article 1180LAllergan had issued a Health Canada-endorsed 'Dear Health Care professional' letter advising of a possibility of distant spread of toxin associated with botulinum toxin A injection. (1) The product monographs for Botox...

• REVIEW OF DATA COLLECTION METHODS USED FOR CHILDREN RECEIVING BOTOX INJECTIONS

  Authors:M Fragala, K Russo, H Dumas, M O'Neil, and J RabinFrom:Physical Therapy (Vol. 80, Issue 5) Peer-Reviewed

  May 2000359 words Brief article, Produ... Purpose: The purposes of this report are to: 1) describe the development of a data collection method for use with children receiving Botox injections in the Spasticity Management Clinic(SMC) of a pediatric...

• Allergan fined for off-label push of Botox

  Author:Alicia AultFrom:Family Practice News (Vol. 40, Issue 15)

  Sept. 15, 2010339 words Brief article 1310LAllergan agreed to plead guilty to charges that it had illegally promoted Botox Therapeutic for uses not approved by the Food and Drug Administration. The U.S. Department of Justice announced the plea and said that...

• Botox for the feet

  From:Diabetes Forecast (Vol. 62, Issue 9)

  Sept. 200955 words Brief article, Repor... 1160LA pilot study has found that botulinum toxin--used in cosmetic Botox injections-reduced foot pain from neuropathy in people with type 2 diabetes. Pain from nerve damage affects more than 25 percent of people with type...

• Respective potencies of Botox and Dysport: a double blind, randomised, crossover study in cervical dystonia; clinically appropriate conversion factor may be less than three. (Cervical Dystonia)

  Author:W. PoeweFrom:Journal of Neurology, Neurosurgery and Psychiatry (Vol. 72, Issue 4) Peer-Reviewed

  Apr. 2002724 words Brief article The issue of apparently different potencies of the two available formulations of botulinum toxin type A--Dysport and Botox--has continued to perplex clinicians for more than a decade. Empirically chosen doses expressed...

• Plastic surgeons using Botox to treat migraine headaches

  From:AORN Journal (Vol. 85, Issue 4) Peer-Reviewed

  Apr. 2007180 words Brief article 1220LBotox is being used by some plastic surgeons to identify and deaden muscles that contribute to the development of migraine headaches, according to a Feb 27, 2007, news release from the Southwestern Medical Center,...

• Treating axilla with Botox

  From:Family Practice News (Vol. 35, Issue 15)

  Aug. 1, 2005192 words Brief article To treat the axilla with Botox, Dr. Glaser first delineates the treatment area by Minors starch/iodine test. She dries the armpit, swabs it with Betadine a couple of centimeters beyond what appears to be the axillary...

• Botox

  From:Formulary (Vol. 44, Issue 7) Peer-Reviewed

  July 200915 words Brief article Botulinum toxin type A (Botox, Allergan) for the treatment of upper-limb spasticity in poststroke adults...

• Allergan, Inc

  From:Applied Clinical Trials (Vol. 10, Issue 10) Peer-Reviewed

  Oct. 200128 words Brief article AIlergan, Inc.'s (Irvine, CA) Botox (botulinum toxin type A) has been approved in the UK for use in the management of severe hyperhidrosis (excessive sweating) of the underarm....

• The lawrence summers memorial award (*)

  From:Multinational Monitor (Vol. 23, Issue 3) Peer-Reviewed

  Mar. 2002514 words Brief article THE MARCH 2002 LAWRENCE SUMMERS MEMORIAL AWARD (*) goes to Allergan, Inc. of Irvine, California for its injectable drug known as Botox. About Botox, the New York Times reported in February 2002: "Without a peep of...

• Botox adds new wrinkle to reference's 11th edition

  From:Ophthalmology Times (Vol. 28, Issue 16) Peer-Reviewed

  Aug. 15, 200398 words Brief article Irvine, CA -- Allergan's Botox (botulinum toxin type A) has officially made its way into the nation's lexicon as a household word. The 11th edition of Merriam-Webster's Collegiate Dictionary, released in July,...

• Cervical Dystonia Indication Expands U.S. Approved Uses of BOTOX[R] Therapy

  From:Dermatology Nursing (Vol. 13, Issue 4) Peer-Reviewed

  Aug. 2001121 words Brief article Allergan, Inc. recently announced it has received United States Food and Drug Administration (FDA) approval of BOTOX[R] (Botulinum Toxin Type A) Purified Neurotoxin Complex for treating adults with cervical dystonia, a...

• Early response key with Botox injections for low back pain

  Author:Betsy BatesFrom:Family Practice News (Vol. 35, Issue 12)

  June 15, 2005384 words Brief article PALM SPRINGS, CALIF. -- Patients with low back pain who experience significant improvement in pain and function after one set of botulinum toxin type A injections are highly likely to respond to subsequent treatments,...